Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety

European Journal of Medicinal Chemistry

Volumn 45, Issue 1, 2010, Pages 63-68

  Güzeldemirci, Nuray Ulusoy ^a   Küçükbasmaci, Ömer ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

1,2,4 Triazole; 1,3,4 Thiadiazole; Antibacterial activity; Antifungal activity; Antimycobacterial activity; Imidazo 2,1 b thiazole

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 1,3,4 THIADIAZOLE DERIVATIVE; 2 ETHYLAMINO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 1,3,4 THIADIAZOLE; 2 METHYLAMINO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 1,3,4 THIADIAZOLE; 2 PHENYLAMINO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 1,3,4 THIADIAZOLE; 4 ALLYL 2,4 DIHYDRO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 3H 1,2,4 TRIAZOLE 3 THIONE; 4 BROMOPHENYL 2,4 DIHYDRO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 3H 1,2,4 TRIAZOLE 3 THIONE; 4 BUTYL 2,4 DIHYDRO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 3H 1,2,4 TRIAZOLE 3 THIONE; 4 CHLOROPHENYL 2,4 DIHYDRO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 3H 1,2,4 TRIAZOLE 3 THIONE; 4 ETHYL 2,4 DIHYDRO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 3H 1,2,4 TRIAZOLE 3 THIONE; 4 METHYL 2,4 DIHYDRO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 3H 1,2,4 TRIAZOLE 3 THIONE; 4 METHYLPHENYL 2,4 DIHYDRO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 3H 1,2,4 TRIAZOLE 3 THIONE; 4 PHENYL 2,4 DIHYDRO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 3H 1,2,4 TRIAZOLE 3 THIONE; 4 PROPYL 2,4 DIHYDRO 5 [[6 (4 BROMOPHENYL)IMIDAZO[2,1 B]THIAZOL 3 YL]METHYL] 3H 1,2,4 TRIAZOLE 3 THIONE; AMPHOTERICIN B; ANTIINFECTIVE AGENT; HYDRAZIDE; IMIDAZO[2,1 B]THIAZOLE DERIVATIVE; ITRACONAZOLE; LEVOFLOXACIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTHRODERMA GYPSEUM; ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON TONSURANS;

ANTI-INFECTIVE AGENTS; FUNGI; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXAZINES; RADIOMETRY; THIADIAZOLES; TRIAZOLES; XANTHENES;

EID: 72049090933     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.09.024     Document Type: Article

References (50)

1. Grange J.M., Zumla A., and Soc J.R. Health 122 (2002) 78-81
2. Cohen T., Sommers B., and Murray M. Lancet Infect. Dis 3 (2003) 13-21
3. Tomioka H. Kekkaku 77 (2002) 573-584
4. Demirbaş N., Demirbaş A., Alpay Karaoǧlu S., and Çelik E. Arkivoc i (2005) 75-91
5. Holla B.S., Gonsalves R., and Shenoy S. Eur. J. Med. Chem. 35 (2000) 267-271
6. Shafiee A., Sayadi A., Roozbahani M.H., Foroumadi A., and Kamal F. Arch. Pharm. Pharm. Med. Chem. 10 (2002) 495-499
7. Sharma S., Gangal S., Rauf A., and Zahin M. Arch. Pharm. Chem. Life Sci. 341 (2008) 714-720
8. Gülerman N.N., Doǧan H.N., Rollas S., Johansson C., and Çelik C. Il Farmaco 56 (2001) 953-958
9. Papakonstantinou-Garoufalias S., Pouli N., Marakos P., and Chytyroglou-Ladas A. Il Farmaco 57 (2002) 973-977
10. Turan-Zitouni G., Kaplanci{dotless}kli{dotless} Z.A., Yi{dotless}ldi{dotless}z M.T., Chevallet P., and Kaya D. Eur. J. Med. Chem. 40 (2005) 607-613
11. Jalilian A.R., Sattari S., Bineshmarvasti M., Shafiee A., and Daneshtalab M. Arch. Pharm. Pharm. Med. Chem. 333 (2000) 347-354
12. Küçükgüzel I., Küçükgüzel S.G., Rollas S., and Kiraz M. Bioorg. Med. Chem. Lett. 11 (2001) 1703-1707
13. Zahajská L., Klimešová V., Kočí J., and Waisser K. J. Kaustová, Arch. Pharm. Pharm. Med. Chem. 337 (2004) 549-555
14. Foroumadi A., Kiani Z., and Soltani F. Il Farmaco 58 (2003) 1073-1076
15. Turan-Zitouni G., Si{dotless}vaci{dotless} M., Ki{dotless}li{dotless}ç F.S., and Erol K. Eur. J. Med. Chem. 36 (2001) 685-689
16. Tozkoparan B., Küpeli E., Yeşilada E., and Ertan M. Bioorg. Med. Chem. 15 (2007) 1808-1814
17. Rabea S.M., El-Koussi N.A., Hassan H.Y., and Aboul-Fadl T. Arch. Pharm. Chem. Life Sci. 339 (2006) 32-40
18. Labanauskas L., Udrenaite E., Gaidelis P., and Brukštus A. Il Farmaco 59 (2004) 255-259
19. Holla B.S., Veerendra B., Shivananda M.K., and Poojary B. Eur. J. Med. Chem. 38 (2003) 759-767
20. Duran A., Doǧan H.N., and Rollas S. Il Farmaco 57 (2002) 559-564
21. Almasirad A., Tabatabai S.A., Faizi M., Kebriaeezadeh A., Mehrabi N., Dalvandi A., and Shafiee A. Bioorg. Med. Chem. Lett. 14 (2004) 6057-6059
22. Küçükgüzel I., Küçükgüzel S.G., Rollas S., Ötük-Sani{dotless}ş G., Özdemir O., Bayrak I., Altuǧ T., and Stables J.P. Il Farmaco 59 (2004) 893-901
23. Kritsanida M., Mouroutsou A., Marakos P., Pouli N., Papakonstantinou-Garoufalias S., Pannecouque C., Witvrouw M., and De Clercq E. Il Farmaco 57 (2002) 253-257
24. Abdel-Aal M.T., El-Sayed W.A., El-Kosy S.M., and El-Ashry E.S.H. Arch. Pharm. Chem. Life Sci. 341 (2008) 307-313
25. Chai B., Qian X., Cao S., Liu H., and Song G. Arkivoc ii (2003) 141-145
26. Varvaresou A., Siatra-Papastaikoudi T., Tsotinis A., Tsantili-Kakoulidou A., and Vamvakides A. Il Farmaco 53 (1998) 320-326
27. Modzelewska-Banachiewicz B., Banachiewicz J., Chodkowska A., Jagiello-Wójtowicz E., and Mazur L. Eur. J. Med. Chem. 39 (2004) 873-877
28. Foroumadi A., Emami S., Hassanzadeh A., Rajaee M., Sokhanvar K., Moshafi M.H., and Shafiee A. Bioorg. Med. Chem. Lett. 15 (2005) 4488-4492
29. Farghaly A.A., Bekhit A.A., and Park J.Y. Arch. Pharm. Pharm. Med. Chem. 333 (2000) 53-57
30. Kadi A.A., El-Brollosy N.R., Al-Deeb O.A., Habib E.E., İbrahim T.M., and El-Emam A.A. Eur. J. Med. Chem. 42 (2007) 235-242
31. Solak N., and Rollas S. Arkivoc xii (2006) 173-181
32. Mamolo M.G., Falagiani V., Zampieri D., Vio L., Banfi E., and Scialino G. Il Farmaco 58 (2003) 631-637
33. Foroumadi A., Soltani F., Moallemzadeh-Haghighi H., and Shafiee A. Arch. Pharm. Chem. Life Sci. 338 (2005) 112-116
34. Schenone S., Brullo C., Bruno O., Bondavalli F., Ranise A., Filippelli W., Rinaldi B., Capuano A., and Falcone G. Bioorg. Med. Chem. 14 (2006) 1698-1705
35. Foroumadi A., Emami S., Pournourmohammadi S., Kharazmi A., and Shafiee A. Eur. J. Med. Chem. 40 (2005) 1346-1350
36. Ergenç N., Ulusoy N., and Ekinci A.C. Il Farmaco 50 (1995) 189-192
37. Ergenç N., Ulusoy N., Çapan G., Ötük Sani{dotless}ş, and M. Kiraz G. Arch. Pharm. Pharm. Med. Chem. 329 (1996) 427-430
38. İlhan E., Ergenç N., Ulusoy N., and Ötük-Sani{dotless}ş G. Pharmazie 51 (1996) 123-124
39. Günay N.S., Çapan G., Ulusoy N., Ergenç N., Ötük G., and Kaya D. Il Farmaco 54 (1999) 826-831
40. Ulusoy N., Ergenç N., Ötük G., and Kiraz M. Boll. Chim. Farmac 140 (2001) 417-421
41. Ulusoy N., Gürsoy A., and Ötük G. Il Farmaco 56 (2001) 947-952
42. Harraga S., Nicod L., Drouhin J.P., Xicluna A., Panouse J.J., Seilles E., and Robert J.F. Eur. J. Med. Chem. 29 (1994) 309-315
43. Ulusoy N., Kiraz M., and Küçükbasmaci{dotless} O. Monatsh. Chem. 133 (2002) 1305-1315
44. Gürsoy E., and Ulusoy Güzeldemirci N. Eur. J. Med. Chem. 42 (2007) 320-326
45. Zamani K., Faghihi K., Sangi M.R., and Zolgharnein J. Turk. J. Chem. 27 (2003) 119-125
46. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Testing, 15th Informational Supplement. M100-s15 (2005), PA. Clinical and Laboratory Standards Institute, Wayne
47. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard. second ed. (2002), M27-A2, Wayne, PA
48. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing Filamentous Fungi; Approved Standard. M38-A (2002), National Commitee for Clinical Laboratory Standards
49. Fernandez-Torres B., Cabanes F.J., Carillo-Munoz A., Esteban A., Inza I., Abarca L., and Guarro J. J. Clin. Microbiol. 40 (2002) 3999-4003
50. Collins L., and Franzblau S.G. Antimicrob. Agents Chemother 41 (1997) 1004-1009